Utepreva Launches FDA-Cleared Endometrial Sampler for Early Detection of Endometrial Cancer
Utepreva LLC has introduced the Utepreva Endometrial Sampler, an innovative FDA 510(k)-cleared device designed for enhanced tissue collection to support early diagnosis of endometrial cancer. The patented, single-use device integrates multiple mechanisms for improved sampling and comfort, aiming to expedite diagnosis in patients at risk of endometrial carcinoma.
The innovative device supports early diagnosis when survival outcomes are most favorable. NEW YORK, April 22, 2026 /PRNewswire/ — Utepreva LLC today announced the launch of the Utepreva Endometrial Sampler, a patented, FDA 510(k)-cleared, single-use endometrial sampling device engineered…